Abstract
Interferon regulatory factor 1 (IRF-1) and IRF-8, also known as interferon consensus sequence binding protein (ICSBP), are important regulators of macrophage differentiation and function. These factors exert their activities through the formation of heterocomplexes. As such, they are coactivators of various interferon-inducible genes in macrophages. To gain better insights into the involvement of these two transcription factors in the onset of the innate immune response and to identify their regulatory network in activated macrophages, DNA microarray was employed. Changes in the expression profile were analyzed in peritoneal macrophages from wild type mice and compared to IRF-1 and IRF-8 null mice, before and following 4 h exposure to IFN-γ and LPS. The expression pattern of 265 genes was significantly changed (up/down) in peritoneal macrophages extracted from wild type mice following treatment with IFN-γ and LPS, while no changes in the expression levels of these genes were observed in samples of the same cell-type from both IRF-1 and IRF-8 null mice. Among these putative target genes, numerous genes are involved in macrophage activity during inflammation. The expression profile of 10 of them was further examined by quantitative RT-PCR. In addition, the promoter regions of three of the identified genes were analyzed by reporter gene assay for the ability to respond to IRF-1 and IRF-8. Together, our results suggest that both IRF-1 and IRF-8 are involved in the transcriptional regulation of these genes. We therefore suggest a broader role for IRF-1 and IRF-8 in macrophages differentiation and maturation, being important inflammatory mediators.
Original language | English |
---|---|
Pages (from-to) | 338-346 |
Number of pages | 9 |
Journal | Molecular Immunology |
Volume | 44 |
Issue number | 4 |
DOIs | |
State | Published - Jan 2007 |
Externally published | Yes |
Bibliographical note
Funding Information:We are grateful to the Arison family donation to the center of DNA Chips, Pediatric Oncology, Chaim Sheba Medical Center and to Prof. Rubinstein from the Weizmann Institute for the generous gift of IRF-1 −/− mice. We thank Dr. Naama Rave-Harel from our laboratory for critical reading of the manuscript, and Dr. Shifra Ben-Dor from the Weizmann Institute for valuable help in data analysis. GR holds the Djerassi Chair in Oncology at the Sackler School of Medicine, and B.Z. Levi is an incumbent of the Lily and Silvian Marcus Chair in Life Sciences at the Technion. This research was partially funded by The Israel Science Foundation (Grant Number: 536/01), by the Center for the Study of Emerging Diseases (CSED), and the fund for the promotion of research at the Technion.
Keywords
- CXCL16
- H28
- ICSBP
- IRF-1
- IRF-8
- Interferon regulatory factors (IRFs)
- LIF
- MAP4K4
- MMP9
- MYC
- Macrophage activation
- PCDH7
- PML
- SOCS7
- Transcriptional regulation